Search clinical trials for: pentoxyphylline (PTX)

Total 1872 results

National Taiwan University Hospital
China Medical University Hospital; Chang Gung Memorial Hospital; Taipei Medical... and other collaborators

Unknown

A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury

Acute Kidney Injury

Taiwan
Meir Medical Center

Withdrawn

Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography

Diabetes Mellitus | Contrast Induced Nephropathy
Cook Group Incorporated
William Cook Europe; MED Institute, Incorporated; Cook Japan Incorporated

Completed

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery (Zilver PTX)

Peripheral Vascular Diseases

United States, Japan, Germany
National Taiwan University Hospital Hsin-Chu Branch

Not yet recruiting

Comparative Efficacy of Different Time Interval Between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients

Stroke

Taiwan
Institute of Liver and Biliary Sciences, India

Completed

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

Non-alcoholic Steatohepatitis

India
C. R. Bard
Bard Ltd

Completed

Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Critical Limb Ischemia

United States, Japan, Austria, Canada, Switzerland, Italy, Belgium, Germany
Centre Hospitalier Universitaire de Nice

Completed

Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS) (B3AV)

Dysfunction of Hemodialysis Vascular Access (Fistula and Graft)

France
Cook Group Incorporated

Completed

Formula PTX Renal Stent Clinical Study

Renal Artery Stenosis

United Kingdom, Germany, Czechia, France
Cook Group Incorporated

Completed

Zilver PTX Drug-Eluting Peripheral Stent Study

Peripheral Arterial Disease

Germany, Switzerland
Proviva Therapeutics, Inc.

Not yet recruiting

A First-in-human (FIH), Multicenter, Open-Label, Phase I Study of PTX-912 in Patients With Locally Advanced/Metastatic Solid Tumors

Solid Tumor | Metastatic Cancer | Advanced Cancer
Prescient Therapeutics, Ltd.

Recruiting

Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort

Advanced Cancer | PTCL

Australia
Muğla Sıtkı Koçman University

Completed

Pentraxin-3 in Hysterectomy Patients

Abdominal Hysterectomy | Laparoscopic Hysterectomy
Palvella Therapeutics, Inc.

Active, not recruiting

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita (VALO-2)

Pachyonychia Congenita

United States
The Second Hospital of Anhui Medical University

Unknown

Comparison of Total Parathyroidectomy With and Without Autotransplantation

Secondary Hyperparathyroidism

China
Turino, Gerard, M.D.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Palvella Therapeutics, Inc.

Unknown

Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita

Pachyonychia Congenita

United States
Akeso

Recruiting

A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

China
Comprehensive Support Project for Oncology Research

Completed

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (RESPECT)

Breast Cancer

Japan
Flanders Medical Research Program

Unknown

The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS)

Peripheral Vascular Disease

Belgium
Kuopio University Hospital
Turku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaborators

Recruiting

Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery (finnptx)

Claudication | Chronic Lower Limb Ischemia | Critical Ischemia | Peripheral Athero Obstructive Disease

Finland
Cook Group Incorporated

Completed

Zilver® PTX™ Global Registry

Peripheral Arterial Disease | Peripheral Vascular Disease

Germany, Italy
Yonsei University

Unknown

Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study

Femoropopliteal Artery Disease

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

HIV Infections

United States, Switzerland
Zhejiang Cancer Hospital

Recruiting

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastric Cancer

China
Pelican Therapeutics, Inc.

Terminated

PTX-35 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Rigshospitalet, Denmark

Unknown

Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis (PESETA)

Peripheral Arterial Disease

Denmark
Heat Biologics

Withdrawn

A Phase 1 Study of PTX-35 in Healthy Volunteers

Healthy Volunteer
French National Agency for Research on AIDS and...

Terminated

Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C

Hepatitis C, Chronic | Liver Fibrosis

France
National Institute of Allergy and Infectious Diseases...
IPPOX Foundation; EuroVacc Foundation; Global Solutions for Infectious Diseases

Withdrawn

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

HIV Infections
Cook Research Incorporated

Completed

Zilver® PTX® V Clinical Study

Peripheral Arterial Disease

United States
Cook Group Incorporated

Completed

Zilver® PTX® in China

Peripheral Artery Disease

China
Centre Hospitalier Universitaire, Amiens

Completed

Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements (JourOpDMS)

Arthroplasty | Length of Stay

France
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Tanta University

Recruiting

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

IBS - Irritable Bowel Syndrome

Egypt
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

Prostate Adenocarcinoma | Male Erectile Disorder | Impotence | Erectile Dysfunction, CTCAE

United States
TCM Biotech International Corp.

Recruiting

A Study of PTX-9908 Injection for Non-resectable HCC With TACE

Carcinoma, Hepatocellular

Taiwan
Providence Therapeutics Holdings Inc.

Completed

PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64

Covid19 Vaccine

Canada
Palvella Therapeutics, Inc.

Recruiting

Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations

Microcystic Lymphatic Malformation

United States
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Proteostasis Therapeutics, Inc.

Completed

Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis

Healthy Volunteer - Complete | Cystic Fibrosis - Complete

United States, Belgium, United Kingdom, France, Germany, Canada, Denmark, New Zealand, Australia
Palvella Therapeutics, Inc.

Recruiting

A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

Pachyonychia Congenita

United States
Ruijin Hospital

Recruiting

Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

Stage IIIC Gastric Cancer

China
Cook Group Incorporated

Completed

Zilver PTX Post-Market Study in Japan

Peripheral Arterial Disease (PAD)
Skane University Hospital

Completed

Drug Eluting Balloon (DEB) vs Plain Old Balloon Angioplasty (POBA) in the Treatment of Failing Dialysis Access

Vascular Diseases | Kidney Diseases
Proteostasis Therapeutics, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Oui Therapeutics, Inc.
National Institute of Mental Health (NIMH)

Enrolling by invitation

A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic

Suicidal Ideation | Suicide, Attempted

United States
Ospedale San Donato

Unknown

Drug Eluting Balloon in peripherAl inTErvention for Below-The-Knee Arteries With Freeway and Lutonix

Peripheral Artery Disease

Italy
Indonesian Cardiovascular Research Center

Completed

Association of Plasma PTX3 Concentration and Outcomes of STEMI

STEMI | Coronary; Ischemic

Indonesia
Institute of Liver and Biliary Sciences, India

Completed

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

Alcoholic Hepatitis

India
Palvella Therapeutics, Inc.

Recruiting

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

BCCs in Gorlin Syndrome Patients

United States, United Kingdom

Search clinical trials for: pentoxyphylline (PTX)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations